Paradigm Biocapital Advisors LP - VERONA PHARMA PLC ownership

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q3 2023$15,100,842
-20.1%
926,432
+3.6%
1.02%
-29.8%
Q2 2023$18,896,222
-2.2%
893,861
-7.1%
1.46%
-20.3%
Q1 2023$19,324,209962,3611.83%
Other shareholders
VERONA PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 4,249,918$69,273,6637.59%
Aisling Capital Management LP 1,115,352$18,180,2387.49%
NEA Management Company, LLC 5,108,563$91,031,4747.03%
Octagon Capital Advisors LP 2,369,000$38,614,7005.93%
Knoll Capital Management, LLC 200,000$3,260,0003.38%
Frazier Life Sciences Management, L.P. 3,014,349$49,133,8893.26%
Perceptive Advisors 4,007,197$65,317,3112.18%
RA Capital Management 6,317,990$102,983,2372.03%
Deep Track Capital, LP 3,187,415$51,954,8652.00%
Carlyle Group Inc. 2,457,500$40,008,1001.74%
View complete list of VERONA PHARMA PLC shareholders